Huapont Life Sciences Co.,Ltd. (SHE:002004)
China
· Delayed Price · Currency is CNY 4.070
+0.010 (0.25%)
Apr 30, 2025, 1:45 PM CST
Huapont Life Sciences Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Jan '21 Jan 1, 2021 | 2015 - 2019 |
| Net Income | -342.59 | 302.12 | 433.48 | 667.81 | 651.73 | Upgrade
|
| Depreciation & Amortization | 969.04 | 884.38 | 800.23 | 747.68 | 696.31 | Upgrade
|
| Other Amortization | 86.53 | 94.3 | 87.87 | 84.44 | 83.09 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.75 | -28.11 | 8.78 | -8.73 | -5.73 | Upgrade
|
| Asset Writedown & Restructuring Costs | 940.51 | 297.12 | 535.85 | 153.83 | 27.68 | Upgrade
|
| Loss (Gain) From Sale of Investments | 172.08 | -8.72 | -436.65 | -308.53 | -255.77 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 6.46 | 7.26 | 19.31 | -35.95 | Upgrade
|
| Other Operating Activities | 324.83 | 740.56 | 1,112 | 719.48 | 848.65 | Upgrade
|
| Change in Accounts Receivable | -914.12 | -587.98 | 59.61 | -1,040 | -128.78 | Upgrade
|
| Change in Inventory | 317.41 | -201.92 | -154.58 | -456.09 | 142.21 | Upgrade
|
| Change in Accounts Payable | 153.83 | 190.68 | 1.46 | 645.38 | 306.92 | Upgrade
|
| Change in Other Net Operating Assets | 20.3 | -10.67 | 21.44 | 33.32 | 67.87 | Upgrade
|
| Operating Cash Flow | 1,625 | 1,589 | 2,408 | 1,270 | 2,373 | Upgrade
|
| Operating Cash Flow Growth | 2.25% | -33.99% | 89.65% | -46.49% | 13.96% | Upgrade
|
| Capital Expenditures | -956.27 | -1,284 | -1,131 | -1,256 | -1,231 | Upgrade
|
| Sale of Property, Plant & Equipment | 35.69 | 72.28 | 35.92 | 59.06 | 29.83 | Upgrade
|
| Cash Acquisitions | - | -3.95 | -15.84 | -41.4 | - | Upgrade
|
| Divestitures | 2.23 | - | - | 1.31 | -0.02 | Upgrade
|
| Investment in Securities | -443.25 | -324.47 | 584.97 | 301.12 | -685.5 | Upgrade
|
| Other Investing Activities | 216.42 | -209.45 | -30.37 | 145.91 | 126.58 | Upgrade
|
| Investing Cash Flow | -1,145 | -1,750 | -556.49 | -790.43 | -1,760 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 15.4 | - | Upgrade
|
| Long-Term Debt Issued | 8,073 | 8,558 | 7,038 | 9,437 | 12,247 | Upgrade
|
| Total Debt Issued | 8,073 | 8,558 | 7,038 | 9,452 | 12,247 | Upgrade
|
| Short-Term Debt Repaid | - | -369.66 | -309.13 | -1,509 | -1,628 | Upgrade
|
| Long-Term Debt Repaid | -7,642 | -8,073 | -7,898 | -10,279 | -11,984 | Upgrade
|
| Total Debt Repaid | -7,642 | -8,442 | -8,207 | -11,788 | -13,612 | Upgrade
|
| Net Debt Issued (Repaid) | 431.52 | 115.44 | -1,169 | -2,336 | -1,365 | Upgrade
|
| Common Dividends Paid | -754.37 | -756.28 | -854.41 | -859.41 | -943.09 | Upgrade
|
| Other Financing Activities | -361.39 | 637.18 | 653.38 | 2,991 | 2,068 | Upgrade
|
| Financing Cash Flow | -684.24 | -3.65 | -1,370 | -203.77 | -239.57 | Upgrade
|
| Foreign Exchange Rate Adjustments | 27.84 | 0.64 | 7.26 | 11.06 | -30.13 | Upgrade
|
| Net Cash Flow | -176.29 | -163.26 | 488.36 | 286.48 | 342.75 | Upgrade
|
| Free Cash Flow | 669.02 | 305.35 | 1,277 | 13.19 | 1,142 | Upgrade
|
| Free Cash Flow Growth | 119.10% | -76.08% | 9579.95% | -98.84% | 75.99% | Upgrade
|
| Free Cash Flow Margin | 5.73% | 2.63% | 9.65% | 0.11% | 10.50% | Upgrade
|
| Free Cash Flow Per Share | 0.34 | 0.15 | 0.65 | 0.01 | 0.58 | Upgrade
|
| Cash Income Tax Paid | 457.41 | 570.87 | 277.96 | 437.81 | 344.62 | Upgrade
|
| Levered Free Cash Flow | -1,080 | 471.25 | 1,290 | 122.24 | 646.93 | Upgrade
|
| Unlevered Free Cash Flow | -1,080 | 686.07 | 1,562 | 410.78 | 997.6 | Upgrade
|
| Change in Net Working Capital | 1,974 | -177.02 | -582.97 | 92.47 | -512.45 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.